Funding rounds: Sunrise, FineHeart, Medical Credit Fund, Inventia Life Science, NorthSea Therapeutics

The Netherlands: NorthSea Therapeutics (NST), a biotech company developing strategies for the treatment of non-alcoholic steatohepatitis (NASH) and other metabolic diseases, has close a US$80m Series C financing round. The round was co-led by Ysios Capital and Forbion Growth and joined by new investors; a large managed care organisation, and Hercules Capital. Existing investors Forbion…

You must be a HMI Subscriber to view this content.

Subscribe Now »